KPV Tripeptide Chemical Structure and Synthesis Methods for Laboratory Research
Last Updated: April 19, 2026
Research Use Only: This content is for laboratory and in vitro research purposes only. Not approved by the FDA for human or veterinary use. Nothing constitutes medical advice.
KPV Tripeptide Chemical Structure and Synthesis Methods for Laboratory Research
KPV is a naturally derived tripeptide fragment that has attracted meaningful interest in preclinical research settings over the past two decades. Its compact three-amino-acid sequence, derived from the C-terminus of alpha-melanocyte-stimulating hormone (alpha-MSH), carries a distinct biochemical profile that researchers continue to study in the context of inflammation modulation, antimicrobial activity, and cellular signaling. Before diving into any downstream research application, it helps to understand what this molecule actually looks like at the structural level and how it is produced for laboratory use.
This article covers the full chemical identity of KPV, including its molecular formula, IUPAC name, stereochemistry, and structural properties, followed by a detailed overview of the solid-phase peptide synthesis (SPPS) methods most commonly used to produce it for research applications.
What Is KPV? A Quick Structural Overview
KPV stands for its three constituent amino acids in single-letter and three-letter code: Lysine (Lys, K) - Proline (Pro, P) - Valine (Val, V). It is the C-terminal tripeptide fragment of alpha-MSH, a neuropeptide belonging to the melanocortin family.
| Property | Value |
|---|---|
| Full Name | Lysyl-Prolyl-Valine |
| IUPAC Name | (2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid |
| Molecular Formula | C16H31N5O4 |
| Molecular Weight | 357.45 g/mol |
| CAS Number | 69079-94-3 |
| Sequence | H-Lys-Pro-Val-OH |
| Net Charge (pH 7) | +1 |
| Peptide Bond Count | 2 |
The molecule consists of three amino acids connected by two peptide bonds. The C-terminus is a free carboxylic acid (-OH), and the N-terminus of the lysine residue features a free alpha-amine. Lysine also contributes an additional epsilon-amine group on its side chain, which is responsible for the molecule's net positive charge under physiological pH conditions.
Amino Acid Residue Properties
Understanding the individual residue contributions helps explain KPV's overall chemical behavior in aqueous and biological matrices.
Lysine (K) - The Charged Anchor
Lysine is a basic, positively charged amino acid at physiological pH. Its epsilon-amino group (pKa approximately 10.5) remains protonated at neutral pH, giving KPV its characteristic +1 charge. This charge contributes to the peptide's solubility in aqueous media and may influence its interaction with negatively charged cell membrane components, including phospholipids and proteoglycans.
Proline (P) - The Conformational Constraint
Proline is structurally unique among the proteinogenic amino acids: its side chain cyclizes back onto the backbone nitrogen, creating a rigid pyrrolidine ring. This forces a fixed phi angle and restricts the conformational freedom of the peptide backbone at this position. In KPV, the proline residue likely contributes to the peptide's resistance to certain proteolytic enzymes, particularly those that require flexible substrate binding.
Valine (V) - The Hydrophobic C-Terminus
Valine is a branched-chain aliphatic amino acid with a hydrophobic isopropyl side chain. As the C-terminal residue of KPV, it contributes limited aqueous interaction surface but may play a role in the peptide's docking orientation at receptor sites and target proteins.
Stereochemistry and Chirality
All three residues in KPV adopt the natural L-configuration (S-stereochemistry at the alpha carbon), consistent with biosynthetically derived peptides. This stereospecificity is important for receptor recognition and biological activity.
Researchers studying structure-activity relationships (SAR) sometimes synthesize D-amino acid analogs or retro-inverso versions of small peptides to evaluate the contribution of specific stereocenters. D-KPV analogs have been explored to some degree, though the natural L-L-L form is the most widely studied configuration in the published literature.
Three-Dimensional Structure and Conformation
KPV is a short, linear tripeptide. Like most tripeptides in solution, it does not adopt a fixed secondary structure such as an alpha-helix or beta-sheet. Instead, it exists as an ensemble of rapidly interconverting conformations in aqueous solution. However, the proline residue does constrain the local geometry at the K-P peptide bond.
NMR spectroscopy studies of alpha-MSH C-terminal fragments suggest that the Lys-Pro turn can adopt a type-II' beta-turn geometry in certain solvent and concentration conditions. Whether this conformation is relevant in receptor-binding contexts remains an area of active research interest.
Solid-Phase Peptide Synthesis: The Standard Production Method
The overwhelming majority of research-grade KPV peptide is produced via solid-phase peptide synthesis (SPPS), a technique pioneered by Bruce Merrifield in the 1960s. SPPS allows researchers and manufacturers to assemble peptides in a stepwise fashion on an insoluble polymer resin support.
General SPPS Workflow for KPV
The synthesis proceeds from the C-terminus to the N-terminus (opposite to the direction of biological translation), attaching each amino acid one at a time:
Resin Loading: Valine (the C-terminal residue) is anchored to the resin via its carboxyl group. Common resins for tripeptides with free C-terminal acids include Wang resin and Rink amide resin (the latter produces a C-terminal amide, which is a distinct compound and should not be confused with the free acid form).
Deprotection: The temporary protecting group on the alpha-amine of the resin-bound residue is removed to expose a free amine for coupling.
Coupling: The next protected amino acid (Proline) is activated and coupled to the free amine using coupling reagents such as HATU, HBTU, or DIC/HOBt. The reaction forms a new peptide bond.
Iteration: Deprotection and coupling are repeated for Lysine (N-terminal residue). Lysine requires orthogonal side-chain protection (typically Boc on the epsilon-amine when using Fmoc chemistry).
Global Deprotection and Cleavage: All side-chain protecting groups are removed simultaneously, and the peptide is cleaved from the resin using a cleavage cocktail. For Fmoc SPPS, this typically involves trifluoroacetic acid (TFA) with scavengers such as triisopropylsilane (TIS) and water.
Precipitation and Isolation: The crude peptide is precipitated in cold diethyl ether and isolated by filtration or centrifugation.
Fmoc vs. Boc SPPS Chemistry
| Feature | Fmoc SPPS | Boc SPPS |
|---|---|---|
| Alpha-amine protecting group | 9-fluorenylmethoxycarbonyl (Fmoc) | tert-Butyloxycarbonyl (Boc) |
| Deprotection condition | Piperidine (base) | TFA (acid) |
| Cleavage condition | TFA cocktail | HF (anhydrous) |
| Safety profile | Milder reagents | Requires HF equipment |
| Suitability for KPV | Standard and preferred | Also viable |
Fmoc chemistry is the current industry standard and is used for the vast majority of KPV production for research use due to its operational safety advantages.
Purification: Achieving High Purity for Research Use
Crude SPPS output contains truncated sequences, deletion peptides, and reagent impurities. High-performance liquid chromatography (HPLC) purification is essential for producing research-grade KPV.
Reverse-phase HPLC (RP-HPLC) is the standard purification method. A C18 stationary phase column with a water/acetonitrile gradient (typically containing 0.1% TFA as an ion-pairing agent) resolves KPV from impurities based on hydrophobicity differences.
Research-grade KPV should be purified to at least 98% purity as confirmed by analytical RP-HPLC. Lower purity preparations introduce confounding variables into experimental results.
Characterization and Identity Confirmation
Proper characterization of synthesized KPV involves multiple orthogonal techniques:
- Analytical RP-HPLC: Confirms purity and elution behavior
- Mass Spectrometry (LC-MS or MALDI-TOF): Confirms molecular weight (expected [M+H]+ = 358.46 Da)
- Amino Acid Analysis (AAA): Confirms residue composition and ratio
- NMR Spectroscopy: Confirms sequence and stereochemistry (research-grade characterization)
Reputable suppliers provide certificates of analysis (CoA) documenting HPLC purity and MS confirmation for each lot.
Solubility and Formulation Considerations for Lab Use
KPV dissolves well in aqueous media due to the lysine epsilon-amine. Researchers typically reconstitute lyophilized KPV in sterile water or low-concentration acetic acid solutions (0.1% to 1%). Stock solutions are generally prepared at 1 mg/mL to 10 mg/mL concentrations.
The peptide is best stored as a lyophilized powder at -20 degrees Celsius. Reconstituted solutions should be aliquoted to minimize freeze-thaw cycles and stored at -80 degrees Celsius for extended periods.
For more on reconstitution and handling best practices, see the companion article: KPV Peptide Storage, Reconstitution, and Lab Handling Guidelines for Researchers.
Frequently Asked Questions
{
"@context": "https://schema.org",
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "What is the molecular weight of KPV tripeptide?",
"acceptedAnswer": {
"@type": "Answer",
"text": "KPV tripeptide has a molecular weight of 357.45 g/mol. Its molecular formula is C16H31N5O4."
}
},
{
"@type": "Question",
"name": "What synthesis method is used to produce research-grade KPV?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Research-grade KPV is predominantly produced via solid-phase peptide synthesis (SPPS), specifically Fmoc chemistry. The peptide is then purified by reverse-phase HPLC to at least 98% purity."
}
},
{
"@type": "Question",
"name": "What is the CAS number for KPV peptide?",
"acceptedAnswer": {
"@type": "Answer",
"text": "The CAS number for KPV (Lys-Pro-Val) is 69079-94-3."
}
},
{
"@type": "Question",
"name": "Is KPV peptide soluble in water?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Yes. KPV is water-soluble due to the positively charged lysine residue at physiological pH. Researchers typically reconstitute it in sterile water or dilute acetic acid for laboratory use."
}
},
{
"@type": "Question",
"name": "What does SPPS stand for in peptide synthesis?",
"acceptedAnswer": {
"@type": "Answer",
"text": "SPPS stands for solid-phase peptide synthesis. It is the standard method for producing short synthetic peptides for research, allowing stepwise assembly of amino acids on an insoluble resin support."
}
}
]
}
Summary
KPV is a compact tripeptide (Lys-Pro-Val) with a molecular weight of 357.45 g/mol and a net positive charge at physiological pH. Its chemical structure reflects its origin as a C-terminal fragment of alpha-MSH, and its proline residue introduces a degree of conformational constraint that distinguishes it from fully flexible linear peptides. Research-grade KPV is produced by Fmoc SPPS, purified by reverse-phase HPLC to at least 98% purity, and characterized by mass spectrometry and amino acid analysis. Proper storage and reconstitution are essential for experimental reproducibility.
References
Brzoska T, Luger TA, Maaser C, Abels C, Bohm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Reviews. 2008;29(5):581-602.
Merrifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society. 1963;85(14):2149-2154.
Luger TA, Scholzen TE, Brzoska T, Bohm M. New insights into the functions of alpha-MSH and related peptides in the immune system. Annals of the New York Academy of Sciences. 2003;994:133-140.
Chan WC, White PD, eds. Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press; 2000.
Ichiyama T, Zhao H, Catania A, et al. Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells. Neuroimmunology. 1999;93(1-2):55-61.
Palmetto Peptides Research Team
All products sold by Palmetto Peptides are intended exclusively for in vitro research and laboratory use. Not for human or veterinary use. Not a drug or supplement.
{
"@context": "https://schema.org",
"@type": "Article",
"headline": "KPV Tripeptide Chemical Structure and Synthesis Methods for Laboratory Research",
"dateModified": "2025-01-15",
"author": {
"@type": "Organization",
"name": "Palmetto Peptides Research Team"
},
"publisher": {
"@type": "Organization",
"name": "Palmetto Peptides"
},
"description": "A technical overview of KPV tripeptide chemical structure, molecular properties, stereochemistry, and solid-phase peptide synthesis methods for laboratory research.",
"mainEntityOfPage": {
"@type": "WebPage"
}
}
Related Articles and Internal Links
- Palmetto Peptides Guide to the Research Peptide KPV (Pillar Page)
- KPV Research Peptide — Product Page
- KPV and NF-κB Pathway Modulation: In Vitro Evidence
- KPV and PepT1 Transporter Uptake: In Vitro Evidence
- KPV Purity Standards and Third-Party Testing Guide
- KPV Storage, Reconstitution, and Lab Handling Guidelines